• Evanthia Giannoula, Alexis Vrachimis, Luca Giovanella, Vasiliki Chatzipavlidou, and Ioannis Iakovou.
• Academic Department of Nuclear Medicine, University Hospital AHEPA, School of Medicine, PC 54621 Thessaloniki, Greece. iiakovou@auth.gr.
• Hell J Nucl Med. 2020 May 1; 23 Suppl: 41-50.

AbstractSince its outbreak in Wuhan, China the SARS-CoV-2 has become a public health emergency of international concern, impacting all areas of daily life, including medical care. Although not in the front line nuclear medicine practice should adjust their standard operating procedures. The adaptations and the flexibility that nuclear thyroidology, among other fields of nuclear medicine, should show during the pandemic, must focus not only in minimizing the risk of infection to staff, patients, and family members, but also in controlling the transmission of the virus while continuing to provide health care services which do not jeopardize patients' prognosis and quality of life. Favorable prognosis and indolent symptoms of most cases of thyroid diseases, allows postponements and rescheduling as well as alternative procedures, provided that they are cautiously considered for each case individually. The objective of the current paper is to provide guidance on how diagnostic and therapeutic management of patients with thyroid diseases can be safely and effectively adjusted during pandemic, in nuclear medicine settings.

23 keywords...

hide…